Navigation Links
PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision
Date:12/8/2009

ANNAPOLIS, Md., Dec. 8 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP) a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that it will hold a conference call at 9:00 a.m. Eastern Time, on Wednesday, December 9, 2009 to provide an update on its recombinant protective antigen (rPA) anthrax vaccine program. The dial-in number for U.S. callers is 866-383-8108 and for international callers is 617-597-5343. The participant passcode is 50815141.

A replay of the conference call will be available beginning at approximately 1:00 p.m. Eastern Time on December 9, 2009 until approximately 11:59 p.m. Eastern Time January 9, 2010. The dial-in number from within the United States is 888-286-8010. For international callers, the dial-in number is 617-801-6888. The participant passcode is 67021476.

The webcast of the conference call will be available until January 9, 2010 and can be accessed from the company's website at http://www.pharmathene.com. A link to the webcast may be found on the Investor Relations section of the website.

About PharmAthene, Inc.

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead product development programs include:

  • SparVax(TM) -- a second generation recombinant protective antigen (rPA) anthrax vaccine
  • Third generation rPA anthrax vaccine
  • Valortim®-- a fully huma
    '/>"/>

SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. PharmAthene Reports Third Quarter 2009 Financial and Operational Results
2. PharmAthene Executives Featured in Anthrax Pathogen Training Video for U.S. Department of Homeland Security
3. PharmAthene Presents Data for Valortim(R) Anthrax Anti-Toxin and Third Generation rPA Anthrax Vaccine Programs at the Bacillus - ACT 2009 Conference
4. PharmAthene to Present at the Rodman and Renshaw Annual Global Investment Conference September 10, 2009
5. PharmAthene Reports Second Quarter 2009 Financial and Operational Results
6. PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009
7. PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants
8. PharmAthenes 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review
9. PharmAthene Reports First Quarter 2009 Financial and Operational Results
10. PharmAthene Announces New Date for First Quarter 2009 Conference Call and Webcast
11. PharmAthene to Host First Quarter 2009 Conference Call and Webcast on Thursday, May 14, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... SAN DIEGO and HONG KONG ... an innovative rare disease therapeutics enterprise, announced today that ... joined the company as vice president, research. Dr. McKew ... research, including key leadership positions at the National Institutes ... to its acquisition by Wyeth). Dr. McKew will lead aTyr,s ...
(Date:10/20/2014)... 20, 2014 Convey Computer , ... team from Iowa State University won first place in ... a Convey HC-2ex, the team’s solution achieved the highest ... than the second place finisher. , Experts from all ... the month long challenge, using a variety of design ...
(Date:10/20/2014)... , October 20, 2014 ... gastrointestinal (GI) disorders and the delivery of care has ... diseases and worrying inequalities in the provision of healthcare ... which was commissioned by United European Gastroenterology (UEG), have ... political and public awareness of the burden of GI ...
(Date:10/20/2014)... October 20, 2014 OncLive® ... Kimmel Cancer Center at Thomas Jefferson University has ... Through the Strategic Alliance Partnership program, the Sidney ... collaborate to raise awareness of the Center’s cutting-edge ... other projects. Clinicians and other health care professionals ...
Breaking Biology Technology:aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 2Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 5Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3
... May 25 aTyr announced today that ... Board of Directors as Executive Chairman. The translation of ... of the future will benefit from Dr. Mendlein,s experience ... as potential replacement protein therapeutics or as targets for ...
... NUREMBERG , Germany ... and Pie,Medical Imaging BV have joined forces to make ... cardiovascular procedures.,This capability is the result of Ziehm Imaging,s ... the Netherlands ), a leading,developer of quantitative analysis software ...
... ... increase sales success need to understand Key Performance Indicators (KPIs) that gauge the potential ... KPIs to generate more business and income in a new article at www.YouCanSell.com ... Albuquerque, ...
Cached Biology Technology:Dr. John Mendlein Joins aTyr Pharma as Executive Chairman 2Dr. John Mendlein Joins aTyr Pharma as Executive Chairman 3Ziehm Imaging and Pie Medical Imaging Announce Cooperation 2Ziehm Imaging and Pie Medical Imaging Announce Cooperation 3Ziehm Imaging and Pie Medical Imaging Announce Cooperation 4Use Key Performance Indicators to Generate Sales Success Says Expert Lenann McGookey Gardner 2
(Date:10/22/2014)... 2014 Aware, Inc. (NASDAQ: AWRE ), ... financial results for its third quarter ended September 30, 2014. ... $6.0 million, an increase of 40% compared to $4.3 million ... third quarter of 2014 was $4.1 million compared to $1.0 ... in the current three month period was primarily due to: ...
(Date:10/18/2014)... stress and stress-related psychiatric disorders are associated ... the molecular mechanisms underlying this relation are ... the development of targeted preventive strategies and ... diseases. This work is presented at the ... Now an international group of researchers from ...
(Date:10/18/2014)... patients with undiagnosed, suspected genetic conditions, a certain type ... molecular diagnostic yield than traditional molecular diagnostic methods, according ... study is being released to coincide with the American ... which sequences the protein­coding region of the genome (the ... a cell or organism), has been rapidly applied in ...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2014 Financial Results 2Aware, Inc. Reports Third Quarter 2014 Financial Results 3Aware, Inc. Reports Third Quarter 2014 Financial Results 4Aware, Inc. Reports Third Quarter 2014 Financial Results 5Aware, Inc. Reports Third Quarter 2014 Financial Results 6Aware, Inc. Reports Third Quarter 2014 Financial Results 7Researchers find why depression and aging linked to increased disease risk 2Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3
... release as much as 1 billion tons of carbon emissions ... reported, according to a new Duke led study. Published ... provides the most comprehensive estimate of global carbon emissions from ... 1.2 billion tons. It suggests there is a high value ...
... MIT neuroscientists has found that brain scans of patients ... will benefit from cognitive behavioral therapy. Social anxiety ... medications. However, it is currently impossible to predict which ... team of researchers from MIT, Boston University (BU) and ...
... disease is the second leading cause of death in children ... million children worldwide every year. These startling statistics from the ... group of undergraduate students from Arizona State University is working ... would detect contaminated drinking water. An interdisciplinary team of ...
Cached Biology News:Destroyed coastal habitats produce significant greenhouse gas 2Predicting how patients respond to therapy 2Predicting how patients respond to therapy 3Students create low-cost biosensor to detect contaminated water in developing nations 2
... The Helios gene gun system, 220-240 V, ... biomaterials into cells. This handheld device employs ... RNA-, and other biomaterial-coated gold microcarriers from ... cartridge directly into target cells. This system ...
Mouse polyclonal antibody raised against a partial recombinant MHC2TA. NCBI Entrez Gene ID = 4261...
... Digital Sight DS-L2 imaging controller is a ... DS-L1, and allows users to comfortably observe, ... DS-L2 controller features an 8.4 inch LCD ... variety of Nikon cameras including the DS-Fi1 ...
Mouse monoclonal antibody to ST8SIA2 - ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2...
Biology Products: